Agios Pharmaceuticals (AGIO) Amortizatization of Intangibles (2012 - 2026)

Agios Pharmaceuticals has reported Amortizatization of Intangibles for 15 years, with the latest figure at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 141.69% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $14.3 million (up 7.73% YoY), and the FY2025 full-year result was $12.4 million, down 14.23% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $3.3 million, up from $3.2 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $5.6 million in Q4 2024, with the low at -$6.2 million in Q4 2022.
• Historically, Amortizatization of Intangibles has averaged $2.1 million across 5 years, with a median of $2.5 million in 2024.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles slumped 358.89% — and 2024, when it soared 292.59%.
• Agios Pharmaceuticals' Amortizatization of Intangibles stood at -$6.2 million in 2022, then soared by 53.22% to -$2.9 million in 2023, then soared by 292.59% to $5.6 million in 2024, then sank by 43.09% to $3.2 million in 2025, then grew by 1.94% to $3.3 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $3.3 million (Q1 2026), $3.2 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.